282 related articles for article (PubMed ID: 20429822)
1. Patient and physician perceptions of treatment of moderate-to-severe chronic pain with oral opioids.
Duensing L; Eksterowicz N; Macario A; Brown M; Stern L; Ogbonnaya A
Curr Med Res Opin; 2010 Jul; 26(7):1579-85. PubMed ID: 20429822
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
4. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey.
McCarberg BH; Nicholson BD; Todd KH; Palmer T; Penles L
Am J Ther; 2008; 15(4):312-20. PubMed ID: 18645331
[TBL] [Abstract][Full Text] [Related]
5. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Candiotti KA; Gitlin MC
Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
[TBL] [Abstract][Full Text] [Related]
6. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
7. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
8. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
9. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
Nwokeji ED; Rascati KL; Brown CM; Eisenberg A
Clin Ther; 2007; 29 Suppl():2589-602. PubMed ID: 18164924
[TBL] [Abstract][Full Text] [Related]
10. Outcome of intrathecal opioids in chronic non-cancer pain.
Roberts LJ; Finch PM; Goucke CR; Price LM
Eur J Pain; 2001; 5(4):353-61. PubMed ID: 11743701
[TBL] [Abstract][Full Text] [Related]
11. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
[TBL] [Abstract][Full Text] [Related]
12. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
Rauck RL
Pain Pract; 2009; 9(6):468-79. PubMed ID: 19874536
[TBL] [Abstract][Full Text] [Related]
13. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations.
Bloodworth D
Phys Med Rehabil Clin N Am; 2006 May; 17(2):355-79. PubMed ID: 16616272
[TBL] [Abstract][Full Text] [Related]
14. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
15. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
16. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment.
Rhodin A; Stridsberg M; Gordh T
Clin J Pain; 2010 Jun; 26(5):374-80. PubMed ID: 20473043
[TBL] [Abstract][Full Text] [Related]
17. Prescription and administration of opioids to hospital in-patients, and barriers to effective use.
Murnion BP; Gnjidic D; Hilmer SN
Pain Med; 2010 Jan; 11(1):58-66. PubMed ID: 19930113
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
19. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
Griessinger N; Sittl R; Likar R
Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
[TBL] [Abstract][Full Text] [Related]
20. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]